CAS 39685-31-9

Cefuracetime

Description:

Cefuracetime, identified by the CAS number 39685-31-9, is a broad-spectrum cephalosporin antibiotic that is primarily used in the treatment of bacterial infections. It exhibits a mechanism of action that involves inhibiting bacterial cell wall synthesis, which ultimately leads to cell lysis and death. Cefuracetime is effective against a variety of Gram-positive and Gram-negative bacteria, making it a valuable option in clinical settings. The compound is typically administered via injection and is known for its relatively good stability in the presence of beta-lactamases, enzymes produced by some bacteria that confer resistance to other antibiotics. Its pharmacokinetic properties allow for effective distribution in body tissues, contributing to its therapeutic efficacy. As with many antibiotics, potential side effects may include allergic reactions, gastrointestinal disturbances, and alterations in normal flora. It is essential to use cefuracetime judiciously to minimize the risk of developing antibiotic resistance.

Formula: C₁₇H₁₇N₃O₈S

InChI: InChI=1S/C17H17N3O8S/c1-8(21)28-6-9-7-29-16-12(15(23)20(16)13(9)17(24)25)18-14(22)11(19-26-2)10-4-3-5-27-10/h3-5,12,16H,6-7H2,1-2H3,(H,18,22)(H,24,25)/b19-11-/t12-,16-/m1/s1

InChI key: InChIKey=YBHZVPYSEUQIII-DYJQDLSISA-N

SMILES: C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\OC)/C3=CC=CO3)=O)C2=O)(SCC1COC(C)=O)[H]

Synonyms:

• (6R,7R)-3-Acetoxymethyl-7-((2Z)-2-(2-furyl)-2-methoxyiminoacetamido)-8-oxo-5-thia-1-azacyclo(4.2.0)oct-2-en-2carbonsaeure
• (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
• 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((2-furanyl(methylimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-
• Cefuracetima
• Cefuracetima [INN-Spanish]
• Cefuracetime [INN:BAN]
• Cefuracetimum
• Cefuracetimum [INN-Latin]
• Skf 81367
• Unii-F69Ea18270

Cefuracetime

CAS: 39685-31-9

Formula: C₁₇H₁₇N₃O₈S

Purity: ≥ 97.0%

Color and Shape: Off-white to beige solid

Molecular weight: 423.4

Ref: 7W-GA8058

Cefuroxime EP Impurity B

CAS: 39685-31-9

Formula: C₁₇H₁₇N₃O₈S

Molecular weight: 423.40

Ref: 4Z-C-445007

Cefuracetime

CAS: 39685-31-9

Cefuracetime

Purity: ≥95%

Molecular weight: 423.4g/mol

Ref: 54-BUP09130

Cefuracetime

CAS: 39685-31-9

Cefuracetime (SKF81367) (SKF81367) is a cephalosporin antibiotic.

Formula: C₁₇H₁₇N₃O₈S

Purity: 98.33%

Color and Shape: Solid

Molecular weight: 423.4

Ref: TM-TQ0056

Cefuracetime

Controlled Product

CAS: 39685-31-9

Impurity Cefuroxime Sodium Impurity B (EP)
Applications Cefuracetime is an impurity of Cefuroxime, which is an antibacterial.
References O’Callaghan, C.H., et al.: Antimicrob. Agents Chemother., 9, 511 (1976), Norrby, R., et al.: J. Antimicrob. Chemother., 3, 355 (1977), Brogden, R.N., et al.: Drugs, 17, 233 (1979), Wozniak, J.R., et al.: Anal. Profiles Drug Subs., 20, 209 (1991),

Formula: C₁₇H₁₇N₃O₈S

Color and Shape: Neat

Molecular weight: 423.40

Ref: TR-C248040

Cefuracetime

CAS: 39685-31-9

Cefuracetam is a beta-lactamase inhibitor that inhibits the activity of β-lactamases, which are enzymes that break down and inactivate penicillins. It is used to treat infections caused by resistant bacteria such as Pseudomonas aeruginosa. Cefuracetam is administered orally or topically for the treatment of ophthalmic diseases, such as bacterial conjunctivitis, and inflammatory diseases such as rheumatoid arthritis. The drug has been shown to inhibit fatty acid synthesis and bile acid formation in rats. Cefuracetam can be administered orally or topically for the treatment of ophthalmic diseases, such as bacterial conjunctivitis, and inflammatory diseases such as rheumatoid arthritis. The drug has been shown to inhibit fatty acid synthesis and bile acid formation in rats.

Formula: C₁₇H₁₇N₃O₈S

Purity: Min. 95%

Molecular weight: 423.4 g/mol

Ref: 3D-PBA68531

Cefuroxime EP Impurity B

CAS: 39685-31-9

Formula: C₁₇H₁₇N₃O₈S

Molecular weight: 423.4

Ref: ST-EA-CP-C265002